Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022

  • ID: 4576867
  • Report
  • Region: Global
  • 112 Pages
  • Frost & Sullivan
1 of 3

The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treatment of the various age-related ailments such as Alzheimer's disease, Parkinson’s disease, osteoarthritis, osteoporosis, and age-related macular degeneration.

However, the industry is shifting focus and is widening its scope to a ‘prevent-manage-repair’ continuum, which is creating novel market opportunities for integrative approaches such innovative dietary supplements, aesthetics procedures, and alternative therapies (such as BHRT). Such approaches, along with advanced clinical therapeutics, such as regenerative medicine and pharmacological targeting of aging (focused on telomeres, rapalogs, senescent cell targeting, and mitochondria-based therapies) are key opportunities in this space.

Digital enablers are likely to gain prominence in the market, driving collaboration between drug and technology firms to cater to the ‘drug-as-a-service’ trend. Digital therapies that amalgamate mobile technology with AI and Big Data analytics for clinical effect will help lower costs and reduce drug side effects. Additionally, digital pills that can track medication consumption will improve drug adherence, a key challenge in the treatment of the elderly population. For example, the ABILIFY MYCITE from Proteus—a digital pill with an ingestible sensor, approved by the FDA for the delivery of Otsuka’s oral aripiprazole tablets—may boost adherence levels if used in the treatment of age-related disorders.

While offering multiple growth opportunities, the market is not without strategic challenges. Aging is an inherently complicated process with multiple complex pathways and mechanisms. Hence, clinical trials to identify novel age management therapies take a long time to show relevant results. The Targeting Aging with Metformin (TAME) clinical trial is a good example. Additionally, aging is still not recognized as a disease by regulatory bodies, making it difficult for companies to position their product launches. Many of the earlier Anti-Aging products launched in the market offered limited results, creating a consumer trust deficit for novel products.

From a regional perspective, the United States and Europe are key markets for age-related products and solutions, with a large patient base, high income levels, and wide exposure to aging management methodologies. However, regions such as APAC, with a growing elderly population and improvement in educational and income levels are expected to emerge as attractive markets.

Key Issues Addressed

  • How attractive is the Anti-Aging market? What is the future market potential?
  • What are the factors driving the demand for age management solutions?
  • Who will be the key users in the future?
  • What will be the focal areas of technology application?
  • What are the business models that will affect the market?
  • What are the factors impacting solution providers?
  • What are the market dynamics around the key trends, as well as market drivers and restraints?
  • Which are the game-changing companies at work?
  • What are the strategic levers to stay on the growth trajectory?
  • What are the key growth opportunities and investment recommendations in this space?
READ MORE
Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary
Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements-Dietary Supplements Segment
Market Engineering Measurements-Conventional Therapies Segment
Market Engineering Measurements-Aesthetic Procedures, Devices, and Products Segment
Big Market Themes
3 Big Predictions

2. Market Overview
Rapidly Aging Global Population
Growing Incidence of Age-related Diseases Creating Significant Cost Pressure
Healthcare Models Not Sustainable in the Long Term
Market Segmentation
Anti-Aging Trends from 2017 to 2022
Regional Insights

3. Competitive Playbook
Market Opportunities
Disruptive Market Participants
Merger, Acquisition, and Partnership Assessment

4. Drivers and Restraints
Market Drivers
Market Restraints

5. Forecasts and Trends
Revenue Forecast
Revenue Forecast by Segment
Revenue Forecast Discussion

6. Segment Analysis-Dietary Supplements
Key Findings
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast by Sub-segment
Revenue Forecast Discussion
Revenue Forecast-Distribution Channels
Key Companies to Watch

7. Segment Analysis-Conventional Therapies
Key Findings for Conventional Therapies
Key Findings for Age-related Ocular Diseases
Key Findings for Neuro-degenerative Diseases
Key Findings for Osteoporosis
Key Findings for Osteoarthritis
Key Findings for Benign Prostatic Hyperplasia
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast by Sub-segment
Revenue Forecast Discussion
Key Companies to Watch

8. Segment Analysis-Aesthetic Procedures, Devices, and Products
Key Findings
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast by Sub-segment
Revenue Forecast Discussion
Key Companies to Watch

9. Future of the Market
Anti-Aging Products-Evolution of Regulatory Policy Needed
Key Future Trends-A Multi-pronged Approach to Manage Aging

10. Growth Opportunities and Companies to Action
Transformation in the Anti-Aging Therapies and Services Ecosystem
Anti-Aging-5 Major Growth Opportunities
Growth Opportunity Impact Analysis
Growth Opportunity 1-Regenerative Medicine: Stem Cell and Gene Therapy
Age-related Applications of Cell Therapy-Companies Analysis
Age-related Applications of Gene Therapy, Small Molecules/Biologics, and Tissue Engineering Applications-Company Analysis
Growth Opportunity 2-Pharmacological Targeting of the Drivers of Aging
Novel Clinical Therapies for Aging Prevention and Management
Prominent Alternative Therapies
Growth Opportunity 3-Digital Patient Engagement
Digital Therapeutics to Manage Age-related Conditions
Better Drug Adherence Using Digitally Enabled Pills
Growth Opportunity 4-Clinically Validated Supplements
Anti-Aging-focused Dietary Supplement Vendors
Novel Technology-Fasting-mimicking Diets
Prominent Anti-Aging Dietary Supplements
Growth Opportunity 5-Comfort and Efficacy of Aesthetic Solutions
Novel Technology-Micronization Nanotechnology for Topical Hyaluronic Acid Application and Stem Cells for Skin Rejuvenation
Strategic Imperatives for Success and Growth

11. The Last Word
The Last Word-3 Big Predictions
Legal Disclaimer
A4M

12. Appendix
List of Exhibits
Conventional Treatment-Competitive Landscape and Pipeline Analysis
Dietary Supplements-Competitive Landscape
Aesthetic Procedures, Devices, and Products-Competitive Landscape
Additional Sources of Information
Market Engineering Methodology

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll